FDA Drug Recalls

Recalls / Class II

Class IID-0531-2025

Product

TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml multidose vial per carton, For intramuscular injection only, Rx Only, ADVANCED PHARMACEUTICAL TECHNOLOGY, INC., 132 South Central Avenue, Elmsford, NY 10523. NDC 57377-200-01

Affected lot / code info
Lot P-24-1; Exp. 02/28/2027

Why it was recalled

Marketed Without an Approved NDA/ANDA

Recalling firm

Firm
Advanced Pharmaceutical Technology, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
132 S Central Ave, Elmsford, New York 10523-3509

Distribution

Quantity
26 vials
Distribution pattern
NY, NJ

Timeline

Recall initiated
2025-05-30
FDA classified
2025-07-16
Posted by FDA
2025-07-02
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0531-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls